Financial Contrast: Biomed Realty Trust (BMR) and Its Peers

Biomed Realty Trust (NYSE: BMR) is one of 76 public companies in the “Commercial REITs” industry, but how does it contrast to its peers? We will compare Biomed Realty Trust to similar companies based on the strength of its institutional ownership, valuation, risk, analyst recommendations, earnings, dividends and profitability.

Dividends

Biomed Realty Trust pays an annual dividend of $1.04 per share and has a dividend yield of 4.4%. Biomed Realty Trust pays out 100.0% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. As a group, “Commercial REITs” companies pay a dividend yield of 3.9% and pay out 90.4% of their earnings in the form of a dividend. Biomed Realty Trust has raised its dividend for 7 consecutive years.

Institutional and Insider Ownership

73.1% of shares of all “Commercial REITs” companies are owned by institutional investors. 7.3% of shares of all “Commercial REITs” companies are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Earnings and Valuation

This table compares Biomed Realty Trust and its peers gross revenue, earnings per share and valuation.

Gross Revenue Net Income Price/Earnings Ratio
Biomed Realty Trust N/A N/A 22.89
Biomed Realty Trust Competitors $537.26 million $100.34 million 436.03

Biomed Realty Trust’s peers have higher revenue and earnings than Biomed Realty Trust. Biomed Realty Trust is trading at a lower price-to-earnings ratio than its peers, indicating that it is currently more affordable than other companies in its industry.

Profitability

This table compares Biomed Realty Trust and its peers’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Biomed Realty Trust 18.98% 3.73% 2.07%
Biomed Realty Trust Competitors 53.64% 5.02% 3.72%

Analyst Ratings

This is a breakdown of recent ratings and recommmendations for Biomed Realty Trust and its peers, as provided by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Biomed Realty Trust 0 0 0 0 N/A
Biomed Realty Trust Competitors 642 2585 2236 24 2.30

As a group, “Commercial REITs” companies have a potential upside of 2.26%. Given Biomed Realty Trust’s peers higher possible upside, analysts clearly believe Biomed Realty Trust has less favorable growth aspects than its peers.

Summary

Biomed Realty Trust peers beat Biomed Realty Trust on 8 of the 9 factors compared.

About Biomed Realty Trust

BioMed Realty Trust, Inc. operates as a real estate investment trust (REIT). The Company is the parent company and general partner of BioMed Realty, L.P. The Company owns, acquires, develops, redevelops, leases and manages laboratory and office space for the life science industry. The Company’s tenants primarily include biotechnology and pharmaceutical companies, scientific research institutions, government agencies and other entities involved in the life science industry. The Company’s properties are located in markets, which has centers for scientific research, including Boston, San Francisco, San Diego, Maryland, New York, New Jersey, Pennsylvania, North Carolina, Seattle, Cambridge (the United Kingdom) and research parks located near or adjacent to universities and their related medical systems. The Company owns interests in properties comprising approximately 17.5 million rentable square feet.

What are top analysts saying about Biomed Realty Trust? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Biomed Realty Trust and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit